age, perennial asthma
Item
children aged 4 to 16 years with an established history of perennial asthma.
boolean
C0001779 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
inhaled corticosteroid
Item
subjects who are treated with an inhaled corticosteroid according to bdp (budesonide) 200-400 µg/day or equivalent during the last 4 weeks before run-in.
boolean
C0586793 (UMLS CUI [1])
fev1 salbutamol
Item
15 minutes after inhaling 200µg of salbutamol, reversible increase in fev1 of at least 12% of the pre-dose value.
boolean
C0748133 (UMLS CUI [1,1])
C0001927 (UMLS CUI [1,2])
willingness to substitute previous controller medication on the twice daily inhalation of fluticasone 100µg bid via diskus®.
Item
willingness to substitute previous controller medication on the twice daily inhalation of fluticasone 100µg bid via diskus®.
boolean
C1321605 (UMLS CUI [1])
C0082607 (UMLS CUI [2])
written informed consent
Item
subjects/guardians who have given written informed consent to participate in the study.
boolean
C0021430 (UMLS CUI [1])
ability to understand and complete a diary record card
Item
subjects /guardians who are able to understand and complete a diary record card (drc).
boolean
C1321605 (UMLS CUI [1])
mini-wright peak flow meter
Item
subjects who are able to use a mini-wright peak flow meter.
boolean
C1321605 (UMLS CUI [1,1])
C0180915 (UMLS CUI [1,2])
contraception
Item
sexually active female adolescents must use adequate contraception.
boolean
C0700589 (UMLS CUI [1])
willingness to refrain from any other controller medication (including anti-leukotrienes) or from regular use of short-acting beta agonists or anticholinergics during the treatment period
Item
willingness to refrain from any other controller medication (including anti-leukotrienes) or from regular use of short-acting beta agonists or anticholinergics during the treatment period.
boolean
C1321605 (UMLS CUI [1])